High incidence of osteonecrosis of femoral head in patients receiving more than 2 g of intravenous methylprednisolone after renal transplantation.
Saisu
T
T
Department of Orthopaedic Surgery, Chiba University, Japan.
Sakamoto
K
K
Yamada
K
K
Kashiwabara
H
H
Yokoyama
T
T
Iida
S
S
Harada
Y
Y
Ikenoue
S
S
Sakamoto
M
M
Moriya
H
H
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005269:Femur; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D010020:Osteonecrosis / Q000139:chemically induced / Q000453:epidemiology*
D007166:Immunosuppressive Agents; D008775:Methylprednisolone